Cape Investment Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $271K | Buy |
7,049
+23
| +0.3% | +$883 | 0.1% | 157 |
|
2025
Q1 | $272K | Sell |
7,026
-158
| -2% | -$6.12K | 0.11% | 145 |
|
2024
Q4 | $243K | Buy |
7,184
+818
| +13% | +$27.7K | 0.1% | 155 |
|
2024
Q3 | $260K | Buy |
6,366
+31
| +0.5% | +$1.27K | 0.11% | 142 |
|
2024
Q2 | $244K | Sell |
6,335
-347
| -5% | -$13.4K | 0.11% | 132 |
|
2024
Q1 | $286K | Sell |
6,682
-4
| -0.1% | -$171 | 0.13% | 114 |
|
2023
Q4 | $248K | Buy |
6,686
+308
| +5% | +$11.4K | 0.12% | 125 |
|
2023
Q3 | $231K | Buy |
6,378
+5,280
| +481% | +$191K | 0.13% | 117 |
|
2023
Q2 | $39.1K | Sell |
1,098
-4,063
| -79% | -$145K | 0.02% | 324 |
|
2023
Q1 | $184K | Buy |
+5,161
| New | +$184K | 0.11% | 129 |
|